Suppliers / Ss Pharma

Ss Pharma

United States 2 duplicate records merged Updated 9 July 2026

Ss Pharma is an API manufacturer based in United States. It holds 21 active US drug master files across a filed portfolio of 18 molecules.

21
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Tafamidis US FDA 2
Treprostinil US FDA 2
Triethylenetetramine US FDA 2
Acebutolol US FDA 1
Atropine US FDA 1
Chlorzoxazone US FDA 1
Estazolam US FDA 1
L-Glutamine US FDA 1
Levocarnitine US FDA 1
Levoketoconazole US FDA 1
Show all 18 molecules on file
Methenamine US FDA 1
Methsuximide US FDA 1
Phenoxybenzamine US FDA 1
Prucalopride US FDA 1
Ramelteon US FDA 1
Rivaroxaban US FDA 1
Stiripentol US FDA 1
Triheptanoin US FDA 1

Also appears on these molecule pages

Questions about Ss Pharma

Does Ss Pharma hold a US DMF or a CEP?
Ss Pharma holds 21 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Ss Pharma make?
18 molecules are on record against Ss Pharma, including Tafamidis, Treprostinil, Triethylenetetramine and Acebutolol. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Ss Pharma?

Ask Fred what the record holds on Ss Pharma, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability